AI Technique Could Offer Tailored Cancer Treatments

When treating patients with early-stage lung cancer, physicians must decide whether to proceed with potentially beneficial but toxic therapies like chemotherapy, radiation, or immunotherapy to remove cancer and reduce the likelihood that it will spread to the brain, or whether to wait and see if lung surgery alone is adequate.

Related Keywords

United States ,Richardj Cote ,Margaret Gladys Smith ,Ramaswamy Govindan ,Changhuei Yang ,Mark Watson ,Department Of Pathology Immunology ,Washington University ,California Institute Of Technology ,Louis School Of Medicine Personalized Initiative ,Washington University School Of Medicine ,Anheuser Busch ,Washington University In St ,Washington University School ,Edward Mallinckrodt Professor ,Anheuser Busch Endowed Chair ,Medical Oncology ,Margaret Gladys Smith Professor ,California Institute ,National Cancer Institute ,National Institutes ,Louis School ,Medicine Personalized Initiative ,Heritage Research Institute ,